UBS O'Connor »

Silence Therapeutics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 72k 21.60
2023-09-30 $967k 98k 9.83
2023-06-30 $541k 98k 5.50
2023-03-31 $591k 95k 6.20
2022-12-31 $1.4M 89k 15.25
2022-09-30 $786k 80k 9.87
2022-06-30 $341k 29k 11.83